Carillon Tower Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$63.1M |
| 2 |
WW
WW International
WW
|
+$57.1M |
| 3 |
Hexcel
HXL
|
+$57.1M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$54.4M |
| 5 |
HealthEquity
HQY
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$70.3M |
| 2 |
WCN
Waste Connections
WCN
|
+$61.3M |
| 3 |
Acuity Brands
AYI
|
+$56.2M |
| 4 |
JetBlue
JBLU
|
+$54.3M |
| 5 |
Martin Marietta Materials
MLM
|
+$53.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.07% |
| 2 | Technology | 19.97% |
| 3 | Consumer Discretionary | 14.41% |
| 4 | Industrials | 14.15% |
| 5 | Financials | 10.91% |
Similar funds
Carillon Tower Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.
- Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
- Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
- Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
- Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
- Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
- Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
- Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.
Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.